Leidos Awarded Contract By Defense Threat Reduction Agency
- Company to Provide Research and Development to Combat Weapons of Mass Destruction
Leidos (NYSE: LDOS) a national security, health and engineering solutions company, was awarded a prime contract by the U.S. Defense Threat Reduction Agency (DTRA) to conduct research and development to combat weapons of mass destruction. The multiple-award indefinite delivery/indefinite quantity (ID/IQ) contract has a five-year base period of performance, a five year option, and a total value of approximately $4 billion for all awardees, if all options are exercised. The contract was awarded under the Combating Weapons of Mass Destruction Research and Technology Development ID/IQ contract.
DTRA is the U.S. Department of Defense's Combat Support Agency for countering weapons of mass destruction. The agency's experts address the entire spectrum of chemical, biological, radiological, nuclear and high yield explosive threats. Under the contract, Leidos will perform research and technology development to provide scientific and technological solutions to meet the DoD's non-proliferation, counterproliferation, and consequence management objectives. Leidos is one of seven contractors eligible to compete for task orders under the contract.
Global Integrated Security Systems Industry 2016 Market Research Report
"Leidos is proud to provide continued support of the mission of the Defense Threat Reduction Agency to safeguard our nation and develop technologies to defeat weapons of mass destruction," said John Fratamico, Leidos group president.
The company, formerly named Science Applications International Corporation, changed its name to Leidos, Inc. on September 27, 2013 in connection with the spin-off of its former technical, engineering and enterprise information technology business, which has assumed the company's former name.
Your company’s press release on ASDNews and to thousands of other journalists and editors? Use our ASDWire press release distribution service.
Source : Leidos
Oct 31 - Nov 3, 2016 - Washington, United States